Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Regulation, Reimbursement Notes From Indonesia

This article was originally published in PharmAsia News

Executive Summary

Indonesia is seeing rapid changes to health care programs after universal insurance coverage was launched at the start of the year, including a tussle with the finance ministry over reimbursement claim payments.

You may also be interested in...



Mixed Impact From Indonesian Foreign Ownership Changes?

A new economic stimulus package from the Indonesian government that includes allowing up to 100% foreign ownership in the pharmaceutical and health sectors has been welcomed by the multinational industry.

Indonesian Insurance Scheme ‘Not Sharia-Compliant’, Muslim Body Says

An edict by a top Muslim council in Indonesia that the country’s national health insurance does not follow Islamic sharia law principles has sparked debate in the world’s most populous Muslim-majority country.

Indonesia’s Struggling Insurance Operator Eyes Premium Rise

Indonesia’s national health insurance operator is seeking an increase in premiums as it struggles with deficits amid soaring claims within the system.

Topics

UsernamePublicRestriction

Register

OM013133

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel